Pacific Biosciences of California, Inc. Interest Expense
Pacific Biosciences of California, Inc. (PACB) reported Interest Expense of $3.58 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-09.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-05-09
- Pacific Biosciences of California, Inc. interest expense for the quarter ending 2024-03-31 was $3.58M, a 1.52% decline year-over-year.
- Pacific Biosciences of California, Inc. interest expense for the quarter ending 2023-12-31 was $3.57M, a 2.11% decline year-over-year.
- Pacific Biosciences of California, Inc. interest expense for the quarter ending 2023-09-30 was $3.59M, a 2.07% decline year-over-year.
- Pacific Biosciences of California, Inc. interest expense for the quarter ending 2023-06-30 was $3.55M, a 3.45% decline year-over-year.
- Pacific Biosciences of California, Inc. interest expense for fiscal 2023 was $14.34M, a 2.36% decline from fiscal 2022.
- Pacific Biosciences of California, Inc. interest expense for fiscal 2022 was $14.69M, a 17.24% increase from fiscal 2021.
- Pacific Biosciences of California, Inc. interest expense for fiscal 2021 was $12.53M, a 4592.88% increase from fiscal 2020.
- Pacific Biosciences of California, Inc. interest expense for fiscal 2020 was $267.00K, a 89.77% decline from fiscal 2019.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2024-03-31 | $3.58M 10-Q · filed 2024-05-09 | $7.15M derived: sum of 2 quarters · filed 2024-05-09 | $10.73M derived: sum of 3 quarters · filed 2024-05-09 | $14.29M derived: sum of 4 quarters · filed 2024-05-09 |
| 2023-12-31 | $3.57M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $7.16M derived: sum of 2 quarters · filed 2024-02-28 | $10.71M derived: sum of 3 quarters · filed 2024-02-28 | $14.34M 10-K · filed 2024-02-28 |
| 2023-09-30 | $3.59M 10-Q · filed 2023-11-03 | $7.14M derived: sum of 2 quarters · filed 2023-11-03 | $10.77M 10-Q · filed 2023-11-03 | $14.42M derived: sum of 4 quarters · filed 2024-05-09 |
| 2023-06-30 | $3.55M 10-Q · filed 2023-08-04 | $7.18M 10-Q · filed 2023-08-04 | $10.83M derived: sum of 3 quarters · filed 2024-05-09 | $14.50M derived: sum of 4 quarters · filed 2024-05-09 |
| 2023-03-31 | $3.63M 10-Q · filed 2024-05-09 | $7.28M derived: sum of 2 quarters · filed 2024-05-09 | $10.94M derived: sum of 3 quarters · filed 2024-05-09 | $14.62M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $3.65M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $7.31M derived: sum of 2 quarters · filed 2024-02-28 | $10.99M derived: sum of 3 quarters · filed 2024-02-28 | $14.69M 10-K · filed 2024-02-28 |
| 2022-09-30 | $3.66M 10-Q · filed 2023-11-03 | $7.34M derived: sum of 2 quarters · filed 2023-11-03 | $11.04M 10-Q · filed 2023-11-03 | $14.52M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $3.68M 10-Q · filed 2023-08-04 | $7.38M 10-Q · filed 2023-08-04 | $10.86M derived: sum of 3 quarters · filed 2024-02-28 | $14.53M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $3.70M 10-Q · filed 2023-05-04 | $7.18M derived: sum of 2 quarters · filed 2024-02-28 | $10.85M derived: sum of 3 quarters · filed 2024-02-28 | $14.44M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $3.48M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $7.15M derived: sum of 2 quarters · filed 2024-02-28 | $10.74M derived: sum of 3 quarters · filed 2024-02-28 | $12.53M 10-K · filed 2024-02-28 |
| 2021-09-30 | $3.67M 10-Q · filed 2022-11-08 | $7.26M derived: sum of 2 quarters · filed 2022-11-08 | $9.05M 10-Q · filed 2022-11-08 | $9.05M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $3.59M 10-Q · filed 2022-08-08 | $5.38M 10-Q · filed 2022-08-08 | $5.38M derived: sum of 3 quarters · filed 2023-02-28 | $5.38M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $1.79M 10-Q · filed 2022-05-06 | $1.79M derived: sum of 2 quarters · filed 2023-02-28 | $1.79M derived: sum of 3 quarters · filed 2023-02-28 | $1.79M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $0.00 derived: sum of 2 quarters · filed 2023-02-28 | $0.00 derived: sum of 3 quarters · filed 2023-02-28 | $267.00K 10-K · filed 2023-02-28 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $0.00 derived: sum of 2 quarters · filed 2021-11-05 | $267.00K 10-Q · filed 2021-11-05 | $945.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $267.00K 10-Q · filed 2021-08-06 | $945.00K derived: sum of 3 quarters · filed 2022-02-28 | $1.61M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $267.00K 10-Q · filed 2021-05-06 | $945.00K derived: sum of 2 quarters · filed 2022-02-28 | $1.61M derived: sum of 3 quarters · filed 2022-02-28 | $2.25M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $678.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $1.34M derived: sum of 2 quarters · filed 2022-02-28 | $1.99M derived: sum of 3 quarters · filed 2022-02-28 | $2.61M 10-K · filed 2022-02-28 |
| 2019-09-30 | $664.00K 10-Q · filed 2020-11-03 | $1.31M derived: sum of 2 quarters · filed 2020-11-03 | $1.93M 10-Q · filed 2020-11-03 | $2.56M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $644.00K 10-Q · filed 2020-08-06 | $1.27M 10-Q · filed 2020-08-06 | $1.90M derived: sum of 3 quarters · filed 2021-02-26 | $2.51M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $625.00K 10-Q · filed 2020-05-08 | $1.25M derived: sum of 2 quarters · filed 2021-02-26 | $1.87M derived: sum of 3 quarters · filed 2021-02-26 | $2.47M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $628.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $1.24M derived: sum of 2 quarters · filed 2021-02-26 | $1.84M derived: sum of 3 quarters · filed 2021-02-26 | $2.42M 10-K · filed 2021-02-26 |
| 2018-09-30 | $616.00K 10-Q · filed 2019-11-07 | $1.21M derived: sum of 2 quarters · filed 2019-11-07 | $1.79M 10-Q · filed 2019-11-07 | $2.42M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | $598.00K 10-Q · filed 2019-08-06 | $1.18M 10-Q · filed 2019-08-06 | $1.80M derived: sum of 3 quarters · filed 2020-02-28 | $2.44M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | $581.00K 10-Q · filed 2019-05-03 | $1.21M derived: sum of 2 quarters · filed 2020-02-28 | $1.84M derived: sum of 3 quarters · filed 2020-02-28 | $2.66M derived: sum of 4 quarters · filed 2020-02-28 |
| 2017-12-31 | $624.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $1.26M derived: sum of 2 quarters · filed 2020-02-28 | $2.08M derived: sum of 3 quarters · filed 2020-02-28 | $2.92M 10-K · filed 2020-02-28 |
| 2017-09-30 | $633.00K 10-Q · filed 2018-11-05 | $1.46M derived: sum of 2 quarters · filed 2018-11-05 | $2.30M 10-Q · filed 2018-11-05 | $3.14M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | $826.00K 10-Q · filed 2018-08-03 | $1.66M 10-Q · filed 2018-08-03 | $2.50M derived: sum of 3 quarters · filed 2019-02-26 | $3.32M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | $838.00K 10-Q · filed 2018-05-02 | $1.68M derived: sum of 2 quarters · filed 2019-02-26 | $2.50M derived: sum of 3 quarters · filed 2019-02-26 | $3.29M derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | $839.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $1.66M derived: sum of 2 quarters · filed 2019-02-26 | $2.46M derived: sum of 3 quarters · filed 2019-02-26 | $3.23M 10-K · filed 2019-02-26 |
| 2016-09-30 | $821.00K 10-Q · filed 2017-11-02 | $1.62M derived: sum of 2 quarters · filed 2017-11-02 | $2.40M 10-Q · filed 2017-11-02 | $3.17M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-06-30 | $795.00K 10-Q · filed 2017-08-02 | $1.57M 10-Q · filed 2017-08-02 | $2.35M derived: sum of 3 quarters · filed 2018-02-26 | $3.09M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-03-31 | $779.00K 10-Q · filed 2017-05-05 | $1.55M derived: sum of 2 quarters · filed 2018-02-26 | $2.29M derived: sum of 3 quarters · filed 2018-02-26 | $3.01M derived: sum of 4 quarters · filed 2018-02-26 |
| 2015-12-31 | $773.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $1.51M derived: sum of 2 quarters · filed 2018-02-26 | $2.23M derived: sum of 3 quarters · filed 2018-02-26 | $2.93M 10-K · filed 2018-02-26 |
| 2015-09-30 | $741.00K 10-Q · filed 2016-11-04 | $1.46M derived: sum of 2 quarters · filed 2016-11-04 | $2.15M 10-Q · filed 2016-11-04 | $2.88M derived: sum of 4 quarters · filed 2017-03-06 |
| 2015-06-30 | $715.00K 10-Q · filed 2016-08-04 | $1.41M 10-Q · filed 2016-08-04 | $2.14M derived: sum of 3 quarters · filed 2017-03-06 | $2.85M derived: sum of 4 quarters · filed 2017-03-06 |
| 2015-03-31 | $697.00K 10-Q · filed 2016-05-05 | $1.42M derived: sum of 2 quarters · filed 2017-03-06 | $2.14M derived: sum of 3 quarters · filed 2017-03-06 | $2.84M derived: sum of 4 quarters · filed 2017-03-06 |
| 2014-12-31 | $725.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | $1.44M derived: sum of 2 quarters · filed 2017-03-06 | $2.14M derived: sum of 3 quarters · filed 2017-03-06 | $2.83M 10-K · filed 2017-03-06 |
| 2014-09-30 | $716.00K 10-Q · filed 2015-11-05 | $1.42M derived: sum of 2 quarters · filed 2015-11-05 | $2.10M 10-Q · filed 2015-11-05 | $2.80M derived: sum of 4 quarters · filed 2016-03-11 |
| 2014-06-30 | $701.00K 10-Q · filed 2015-08-05 | $1.39M 10-Q · filed 2015-08-05 | $2.08M derived: sum of 3 quarters · filed 2016-03-11 | $2.77M derived: sum of 4 quarters · filed 2016-03-11 |
| 2014-03-31 | $686.00K 10-Q · filed 2015-05-05 | $1.38M derived: sum of 2 quarters · filed 2016-03-11 | $2.06M derived: sum of 3 quarters · filed 2016-03-11 | $2.74M derived: sum of 4 quarters · filed 2016-03-11 |
| 2013-12-31 | $693.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | $1.38M derived: sum of 2 quarters · filed 2016-03-11 | $2.05M derived: sum of 3 quarters · filed 2016-03-11 | $2.48M 10-K · filed 2016-03-11 |
| 2013-09-30 | $686.00K 10-Q · filed 2014-11-05 | $1.36M derived: sum of 2 quarters · filed 2014-11-05 | $1.78M 10-Q · filed 2014-11-05 | $1.85M derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-06-30 | $673.00K 10-Q · filed 2014-08-05 | $1.10M 10-Q · filed 2014-08-05 | $1.17M derived: sum of 3 quarters · filed 2015-03-12 | $1.23M derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-03-31 | $426.00K 10-Q · filed 2014-05-08 | $493.00K derived: sum of 2 quarters · filed 2015-03-12 | $561.00K derived: sum of 3 quarters · filed 2015-03-12 | $630.00K derived: sum of 4 quarters · filed 2015-03-12 |
| 2012-12-31 | $67.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $135.00K derived: sum of 2 quarters · filed 2015-03-12 | $204.00K derived: sum of 3 quarters · filed 2015-03-12 | $274.00K 10-K · filed 2015-03-12 |
| 2012-09-30 | $68.00K 10-Q · filed 2013-11-12 | $137.00K derived: sum of 2 quarters · filed 2013-11-12 | $207.00K 10-Q · filed 2013-11-12 | |
| 2012-06-30 | $69.00K 10-Q · filed 2013-08-09 | $139.00K 10-Q · filed 2013-08-09 | ||
| 2011-12-31 | $287.00K 10-K · filed 2014-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |